ARCHIVES

As Zeneca Buys Salick, Implications For Oncology Managed Care Uncertain

This article is from The Cancer Letter archive.

Vol. 23 No. 13 | April 4, 1997

Download PDF Visit The Full Archive

Related Articles

As Avastin Decision Nears, Patient Groups Split On PFS In Front Line Breast Cancer.

February 22, 2008

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

December 31, 2010

Drug Shortages Prompt Doctors, Societies to Consider Non-Profit Pharma Company

September 9, 2011

Bush Budget Proposal a $511 Million Cut For NIH.

February 9, 2007

NIH Programs: Mouse Is next In Line For DNA Sequencing

October 29, 1999

Gene Chips Diagnose Four Childhood Cancers.

June 15, 2001